The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
Authors
Keywords
T cells, Oxazaphosphorines, Immune reactivation, Immunosuppression
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 78, Issue 4, Pages 661-671
Publisher
Springer Nature
Online
2016-09-19
DOI
10.1007/s00280-016-3152-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer
- (2016) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low dose cyclophosphamide: Mechanisms of T cell modulation
- (2016) Mutsa Tatenda Madondo et al. CANCER TREATMENT REVIEWS
- Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide
- (2016) Alexandra Audemard-Verger et al. PLoS One
- Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer
- (2016) Kai Li et al. OncoTargets and Therapy
- The Immune System in Cancer Prevention, Development and Therapy
- (2015) Serge M. Candeias et al. Anti-Cancer Agents in Medicinal Chemistry
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
- (2015) Soranobu Ninomiya et al. BLOOD
- The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
- (2015) C. C. Engels et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- An immunological view of chemotherapy
- (2015) Kangla Tsung et al. Immunotherapy
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent
- (2015) Christopher G Kanakry et al. OncoImmunology
- Microbiome, Inflammation, and Cancer
- (2014) Ralph Francescone et al. CANCER JOURNAL
- Harnessing the Intestinal Microbiome for Optimal Therapeutic Immunomodulation
- (2014) S. Viaud et al. CANCER RESEARCH
- Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis
- (2014) Sarah Dimeloe et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation
- (2013) In-Wha Kim et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation
- (2013) Lynae M. Brayboy et al. FERTILITY AND STERILITY
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis
- (2012) Melanie S. Joy et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein
- (2012) O. A. Patutina et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
- (2012) Shiwen Peng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
- (2012) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Improvement of Antitumor Effect of Intratumoral Injection of Immature Dendritic Cells Into Irradiated Tumor by Cyclophosphamide in Mouse Colon Cancer Model
- (2012) Cheol-Hun Son et al. JOURNAL OF IMMUNOTHERAPY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2010) Soranobu Ninomiya et al. ANNALS OF HEMATOLOGY
- Extended Follow-up of Autologous Bone Marrow Transplantation with 4-Hydroperoxycyclophosphamide (4-HC) Purging for Indolent or Transformed Non-Hodgkin Lymphomas
- (2010) Yvette L. Kasamon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients
- (2010) S. Viaud et al. CANCER RESEARCH
- Selective Depletion of CD4+CD25+Foxp3+Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels
- (2010) Jie Zhao et al. CANCER RESEARCH
- CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy
- (2010) Yuchun Cao et al. CLINICAL IMMUNOLOGY
- Cyclophosphamide Induces Dynamic Alterations in the Host Microenvironments Resulting in a Flt3 Ligand-Dependent Expansion of Dendritic Cells
- (2010) Mohamed L. Salem et al. JOURNAL OF IMMUNOLOGY
- Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
- (2009) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
- (2009) JS McCune et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2009) Takeshi Yoshikawa et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Drug Focus: Pharmacogenetic studies related to cyclophosphamide-based therapy
- (2009) Navin Pinto et al. PHARMACOGENOMICS
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
- (2008) Robbert G. van der Most et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox)
- (2008) Gergely Szakács et al. DRUG DISCOVERY TODAY
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started